Curtis Price, Jr.

Curtis Price, Jr. serves as a Contract Specialist at Naval Medical Center Portsmouth (N00183), where he plays a critical role in securing mission-critical medical equipment and supplies essential to operational readiness and clinical excellence. He manages the full lifecycle of acquisitions for high-precision surgical instruments, electromedical devices, diagnostic supplies, and in-vitro diagnostic substances, ensuring compliance with Defense Federal Acquisition Regulation Supplement (DFARS) requirements and Navy medical standards. His work directly supports the center’s mandate to maintain cutting-edge healthcare capabilities for active-duty personnel, veterans, and their families, with a focus on timely, compliant, and technically sound procurement outcomes. Price collaborates with a diverse range of vendors, including manufacturers of surgical and medical instruments, laboratory equipment suppliers, and specialized biomedical service providers. While no single contractor dominates his portfolio, he consistently engages with firms possessing FDA registrations, ISO 13485 certification, and defense supply chain qualifications. His contracting approach emphasizes vendor reliability, technical documentation compliance, and post-award performance oversight to ensure equipment interoperability and clinical safety. He demonstrates a strong commitment to small business participation, with over one-third of his acquisitions structured as Total Small Business Set-Asides under FAR 19.5. Though no specific socioeconomic set-asides are dominant, his pattern reflects a deliberate effort to expand opportunities for small manufacturers and service providers capable of meeting stringent medical and military specifications. His procurement focus centers on NAICS 811219 (Medical and Diagnostic Laboratory Services), 339112 (Surgical Instrument Manufacturing), and 339113 (Surgical Appliance and Supplies Manufacturing), indicating deep expertise in procuring precision medical hardware and consumables. He routinely evaluates technical specifications for sterilization compatibility, electromagnetic interference standards, and FDA-cleared status, ensuring all acquisitions align with clinical and operational requirements.